Table of Contents 1 Gene Therapies for Cancer Treatment Market Overview 1.1 Product Overview and Scope of Gene Therapies for Cancer Treatment 1.2 Classification of Gene Therapies for Cancer Treatment by Types 1.2.1 Global Gene Therapies for Cancer Treatment Revenue Comparison by Types (2019-2024) 1.2.2 Global Gene Therapies for Cancer Treatment Revenue Market Share by Types in 2018 1.2.3 Gene Induced Immunotherapy 1.2.4 Oncolytic Virotherapy 1.2.5 Gene Transfer 1.3 Global Gene Therapies for Cancer Treatment Market by Application 1.3.1 Global Gene Therapies for Cancer Treatment Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Other 1.4 Global Gene Therapies for Cancer Treatment Market by Regions 1.4.1 Global Gene Therapies for Cancer Treatment Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) Gene Therapies for Cancer Treatment Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Gene Therapies for Cancer Treatment Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gene Therapies for Cancer Treatment Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) Gene Therapies for Cancer Treatment Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gene Therapies for Cancer Treatment Status and Prospect (2014-2024) 1.5 Global Market Size of Gene Therapies for Cancer Treatment (2014-2024) 2 Manufacturers Profiles 2.1 Novartis 2.1.1 Business Overview 2.1.2 Gene Therapies for Cancer Treatment Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Novartis Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.2 Kite Pharma 2.2.1 Business Overview 2.2.2 Gene Therapies for Cancer Treatment Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Kite Pharma Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.3 Amgen 2.3.1 Business Overview 2.3.2 Gene Therapies for Cancer Treatment Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Amgen Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.4 Shanghai Sunway 2.4.1 Business Overview 2.4.2 Gene Therapies for Cancer Treatment Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Shanghai Sunway Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.5 Sibiono 2.5.1 Business Overview 2.5.2 Gene Therapies for Cancer Treatment Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Sibiono Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018) 3 Global Gene Therapies for Cancer Treatment Market Competition, by Players 3.1 Global Gene Therapies for Cancer Treatment Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 Gene Therapies for Cancer Treatment Players Market Share 3.2.2 Top 10 Gene Therapies for Cancer Treatment Players Market Share 3.3 Market Competition Trend 4 Global Gene Therapies for Cancer Treatment Market Size by Regions 4.1 Global Gene Therapies for Cancer Treatment Revenue and Market Share by Regions 4.2 North America Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 4.3 Europe Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 4.5 South America Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 5 North America Gene Therapies for Cancer Treatment Revenue by Countries 5.1 North America Gene Therapies for Cancer Treatment Revenue by Countries (2014-2019) 5.2 USA Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 5.3 Canada Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 5.4 Mexico Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 6 Europe Gene Therapies for Cancer Treatment Revenue by Countries 6.1 Europe Gene Therapies for Cancer Treatment Revenue by Countries (2014-2019) 6.2 Germany Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 6.3 UK Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 6.4 France Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 6.5 Russia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 6.6 Italy Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Gene Therapies for Cancer Treatment Revenue by Countries 7.1 Asia-Pacific Gene Therapies for Cancer Treatment Revenue by Countries (2014-2019) 7.2 China Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 7.3 Japan Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 7.4 Korea Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 7.5 India Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 8 South America Gene Therapies for Cancer Treatment Revenue by Countries 8.1 South America Gene Therapies for Cancer Treatment Revenue by Countries (2014-2019) 8.2 Brazil Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 8.3 Argentina Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 8.4 Colombia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue Gene Therapies for Cancer Treatment by Countries 9.1 Middle East and Africa Gene Therapies for Cancer Treatment Revenue by Countries (2014-2019) 9.2 Saudi Arabia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 9.3 UAE Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 9.4 Egypt Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 9.5 Nigeria Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 9.6 South Africa Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) 10 Global Gene Therapies for Cancer Treatment Market Segment by Type 10.1 Global Gene Therapies for Cancer Treatment Revenue and Market Share by Type (2014-2019) 10.2 Global Gene Therapies for Cancer Treatment Market Forecast by Type (2019-2024) 10.3 Gene Induced Immunotherapy Revenue Growth Rate (2014-2024) 10.4 Oncolytic Virotherapy Revenue Growth Rate (2014-2024) 10.5 Gene Transfer Revenue Growth Rate (2014-2024) 11 Global Gene Therapies for Cancer Treatment Market Segment by Application 11.1 Global Gene Therapies for Cancer Treatment Revenue Market Share by Application (2014-2019) 11.2 Gene Therapies for Cancer Treatment Market Forecast by Application (2019-2024) 11.3 Hospital Revenue Growth (2014-2019) 11.4 Clinic Revenue Growth (2014-2019) 11.5 Other Revenue Growth (2014-2019) 12 Global Gene Therapies for Cancer Treatment Market Size Forecast (2019-2024) 12.1 Global Gene Therapies for Cancer Treatment Market Size Forecast (2019-2024) 12.2 Global Gene Therapies for Cancer Treatment Market Forecast by Regions (2019-2024) 12.3 North America Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024) 12.4 Europe Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024) 12.6 South America Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Gene Therapies for Cancer Treatment Picture Table Product Specifications of Gene Therapies for Cancer Treatment Table Global Gene Therapies for Cancer Treatment and Revenue (Million USD) Market Split by Product Type Figure Global Gene Therapies for Cancer Treatment Revenue Market Share by Types in 2018 Figure Gene Induced Immunotherapy Picture Figure Oncolytic Virotherapy Picture Figure Gene Transfer Picture Table Global Gene Therapies for Cancer Treatment Revenue (Million USD) by Application (2014-2024) Figure Gene Therapies for Cancer Treatment Revenue Market Share by Applications in 2018 Figure Hospital Picture Figure Clinic Picture Figure Other Picture Table Global Market Gene Therapies for Cancer Treatment Revenue (Million USD) Comparison by Regions 2014-2024 Figure North America Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Europe Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Asia-Pacific Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure South America Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Middle East and Africa Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Global Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate (2014-2024) Table Novartis Basic Information, Manufacturing Base and Competitors Table Novartis Gene Therapies for Cancer Treatment Type and Applications Table Novartis Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Kite Pharma Basic Information, Manufacturing Base and Competitors Table Kite Pharma Gene Therapies for Cancer Treatment Type and Applications Table Kite Pharma Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Amgen Basic Information, Manufacturing Base and Competitors Table Amgen Gene Therapies for Cancer Treatment Type and Applications Table Amgen Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Shanghai Sunway Basic Information, Manufacturing Base and Competitors Table Shanghai Sunway Gene Therapies for Cancer Treatment Type and Applications Table Shanghai Sunway Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Sibiono Basic Information, Manufacturing Base and Competitors Table Sibiono Gene Therapies for Cancer Treatment Type and Applications Table Sibiono Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Global Gene Therapies for Cancer Treatment Revenue (Million USD) by Players (2014-2019) Table Global Gene Therapies for Cancer Treatment Revenue Share by Players (2014-2019) Figure Global Gene Therapies for Cancer Treatment Revenue Share by Players in 2017 Figure Global Gene Therapies for Cancer Treatment Revenue Share by Players in 2018 Figure Global Top 5 Players Gene Therapies for Cancer Treatment Revenue Market Share in 2018 Figure Global Top 10 Players Gene Therapies for Cancer Treatment Revenue Market Share in 2018 Figure Global Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019) Table Global Gene Therapies for Cancer Treatment Revenue (Million USD) by Regions (2014-2019) Table Global Gene Therapies for Cancer Treatment Revenue Market Share by Regions (2014-2019) Figure Global Gene Therapies for Cancer Treatment Revenue Market Share by Regions (2014-2019) Figure Global Gene Therapies for Cancer Treatment Revenue Market Share by Regions in 2018 Figure North America Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Figure Europe Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Figure Asia-Pacific Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Figure South America Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Figure Middle East and Africa Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Table North America Gene Therapies for Cancer Treatment Revenue by Countries (2014-2019) Table North America Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2014-2019) Figure North America Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2014-2019) Figure North America Gene Therapies for Cancer Treatment Revenue Market Share by Countries in 2018 Figure USA Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Figure Canada Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Figure Mexico Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Table Europe Gene Therapies for Cancer Treatment Revenue (Million USD) by Countries (2014-2019) Figure Europe Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2014-2019) Figure Europe Gene Therapies for Cancer Treatment Revenue Market Share by Countries in 2018 Figure Germany Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Figure UK Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Figure France Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Figure Russia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Figure Italy Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Table Asia-Pacific Gene Therapies for Cancer Treatment Revenue (Million USD) by Countries (2014-2019) Figure Asia-Pacific Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2014-2019) Figure Asia-Pacific Gene Therapies for Cancer Treatment Revenue Market Share by Countries in 2018 Figure China Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Figure Japan Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Figure Korea Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Figure India Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Figure Southeast Asia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Table South America Gene Therapies for Cancer Treatment Revenue by Countries (2014-2019) Table South America Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2014-2019) Figure South America Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2014-2019) Figure South America Gene Therapies for Cancer Treatment Revenue Market Share by Countries in 2018 Figure Brazil Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Figure Argentina Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Figure Colombia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Table Middle East and Africa Gene Therapies for Cancer Treatment Revenue (Million USD) by Countries (2014-2019) Table Middle East and Africa Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Gene Therapies for Cancer Treatment Revenue Market Share by Countries in 2018 Figure Saudi Arabia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Figure UAE Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Figure Egypt Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Figure Nigeria Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Figure South Africa Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019) Table Global Gene Therapies for Cancer Treatment Revenue (Million USD) by Type (2014-2019) Table Global Gene Therapies for Cancer Treatment Revenue Share by Type (2014-2019) Figure Global Gene Therapies for Cancer Treatment Revenue Share by Type (2014-2019) Figure Global Gene Therapies for Cancer Treatment Revenue Share by Type in 2019 Table Global Gene Therapies for Cancer Treatment Revenue Forecast by Type (2019-2024) Figure Global Gene Therapies for Cancer Treatment Market Share Forecast by Type (2019-2024) Figure Global Gene Induced Immunotherapy Revenue Growth Rate (2014-2019) Figure Global Oncolytic Virotherapy Revenue Growth Rate (2014-2019) Figure Global Gene Transfer Revenue Growth Rate (2014-2019) Table Global Gene Therapies for Cancer Treatment Revenue by Application (2014-2019) Table Global Gene Therapies for Cancer Treatment Revenue Share by Application (2014-2019) Figure Global Gene Therapies for Cancer Treatment Revenue Share by Application (2014-2019) Figure Global Gene Therapies for Cancer Treatment Revenue Share by Application in 2019 Table Global Gene Therapies for Cancer Treatment Revenue Forecast by Application (2019-2024) Figure Global Gene Therapies for Cancer Treatment Market Share Forecast by Application (2019-2024) Figure Global Hospital Revenue Growth Rate (2014-2019) Figure Global Clinic Revenue Growth Rate (2014-2019) Figure Global Other Revenue Growth Rate (2014-2019) Figure Global Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024) Table Global Gene Therapies for Cancer Treatment Revenue (Million USD) Forecast by Regions (2019-2024) Figure Global Gene Therapies for Cancer Treatment Revenue Market Share Forecast by Regions (2019-2024) Figure North America Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024) Figure Europe Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024) Figure Asia-Pacific Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024) Figure South America Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024) Figure Middle East and Africa Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024)

Novartis Kite Pharma Amgen Shanghai Sunway Sibiono